共 50 条
- [31] Effect of Moxidectin on CYP3A4 Activity as Evaluated by Oral Midazolam Pharmacokinetics in Healthy Subjects CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (02): : 151 - 157
- [33] Drug-Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1253 - 1263
- [34] Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans PHARMACOGENOMICS JOURNAL, 2009, 9 (01): : 49 - 60
- [35] Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans The Pharmacogenomics Journal, 2009, 9 : 49 - 60
- [36] Effect of NIPRISAN® on CYP3A4 activity in vitro European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 115 - 118
- [37] Genetic epidemiology of induced CYP3A4 activity PHARMACOGENETICS AND GENOMICS, 2011, 21 (10): : 642 - 651
- [39] Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test Cancer Chemotherapy and Pharmacology, 2008, 62 : 373 - 377